Maker of Risperdal hit with $1.1 billion fraud verdict 
Published: April 18, 2012
Tags: consumer protection, fraud, Medicaid, Medicaid fraud, Risperdal
The maker of the antipsychotic drug Risperdal has been ordered to pay $1.1 billion for defrauding Arkansas’ Medicaid program.
Drug firms not liable for Medicaid fraud
By:
Pat Murphy
Published: October 20, 2009
Tags: drug price-fixing, Medicaid fraud
Prescription drug companies did not artificially inflate their prices in order to defraud a state Medicaid program, the Alabama Supreme Court has ruled in reversing jury verdicts exceeding $274 million.
